Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity

Abby M Green1,2, Rachel A DeWeerd1, David R O'Leary1

  • 1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.

EMBO Reports
|August 4, 2021
PubMed

Insights

The chaperonin-containing TCP-1 (CCT) complex regulates APOBEC3A (A3A) enzyme activity. Disruption of CCT function increases A3A-induced DNA damage and mutations, impacting cancer genomes.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • APOBEC3 cytidine deaminases cause somatic mutations in cancer genomes.
  • APOBEC3 enzymes normally restrict viral genomes but can mutate cellular DNA.
  • Regulation of APOBEC3 activity and cellular DNA interaction is poorly understood.

Purpose of the Study:

  • To identify regulators of APOBEC3A (A3A) activity using proteomics.
  • To investigate the role of protein interactors in A3A-mediated mutagenesis.
  • To explore the link between CCT complex function and A3A mutational signatures in cancer.

Main Methods:

  • Proteomic analysis to identify A3A protein interactors.
  • Depletion studies to assess the impact of CCT complex on A3A activity.
  • Bioinformatic evaluation of cancer genomes for mutational signatures.

Main Results:

  • The chaperonin-containing TCP-1 (CCT) complex was identified as an A3A interactor.
  • Depletion of CCT led to increased A3A-induced DNA damage and cytotoxicity.
  • Cancer genomes showed enrichment of A3A mutational signatures in tumors with CCT gene mutations.

Conclusions:

  • The CCT complex interacts with and likely regulates A3A activity.
  • Disruption of CCT function enhances A3A-mediated mutagenesis.
  • CCT complex dysfunction contributes to A3A mutational patterns in cancer.

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.1K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K